MDCX
Medicus Pharma Ltd.
0.40
2 x 0.31
2 x 0.50
bid
ask
-
0.05
10.37%
2 @ 08:59 AM
0.42 +0.02 (4.97%)
| Ytd | -73.86% | |
| 1y | -87.58% |
0.38
day range
0.46
0.25
52 week range
3.69
| Open | 0.45 | Prev Close | 0.45 | Low | 0.38 | High | 0.46 | Mkt Cap | 22.66M |
| Vol | 1.80M | Avg Vol | 4.15M | EPS | -2.63 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.34 | 200-d Avg | 1.27 | 1yr Est | 7.80 |
| Income Statement | |||
| Operating Expenses | 8.60M | ||
| Research and Development Expense | 2.70M | ||
| Selling, General and Administrative Expense | 5.89M | ||
| Operating Income | -8.60M | ||
| Interest Expense | 374.71K | ||
| Net Income | -9.04M | ||
| Net Income Common Stock | -9.04M | ||
| Net Income Common Stock (USD) | -9.04M | ||
| Consolidated Income | -9.04M | ||
| Earnings per Basic Share | -0.31 | ||
| Earnings per Basic Share (USD) | -0.31 | ||
| Earnings per Diluted Share | -0.31 | ||
| Earning Before Interest & Taxes (EBIT) | -8.67M | ||
| Earning Before Interest & Taxes (USD) | -8.67M | ||
| Weighted Average Shares | 29.54M | ||
| Weighted Average Shares Diluted | 29.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.37M | ||
| Cash and Equivalents (USD) | 6.37M | ||
| Current Assets | 7.28M | ||
| Property, Plant & Equipment Net | 144.33K | ||
| Total Assets | 7.43M | ||
| Debt Current | 2.49M | ||
| Total Debt | 2.53M | ||
| Current Liabilities | 5.95M | ||
| Debt Non-Current | 45.21K | ||
| Total Liabilities | 6.00M | ||
| Accumulated Retained Earnings (Deficit) | -73.39M | ||
| Accumulated Other Comprehensive Income | -190.51K | ||
| Shareholders Equity | 1.33M | ||
| Shareholders Equity (USD) | 1.33M | ||
| Assets Non-Current | 144.33K | ||
| Total Debt (USD) | 2.53M | ||
| Liabilities Non-Current | 45.21K | ||
| Trade and Non-Trade Payables | 2.43M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 6.83M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.34M | ||
| Issuance (Purchase) of Equity Shares | 10.01M | ||
| Issuance (Repayment) of Debt Securities | -3.18M | ||
| Net Cash Flow from Operations | -8.97M | ||
| Effect of Exchange Rate Changes on Cash | -195.06K | ||
| Share Based Compensation | 599.31K | ||